Form 4: Bayview Legacy Sells 70,000 Arteris Shares

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 70,000 shares of common stock via a pre-arranged 10b5-1 trading plan.

Summary

• Bayview Legacy, LLC sold a total of 70,000 shares of Arteris, Inc. (AIP) common stock on June 8, 2026.
• The sales were executed in two tranches: 42,449 shares at a weighted average price of $34.7417 and 27,551 shares at a weighted average price of $35.1596.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2025.
• Following these transactions, Bayview Legacy, LLC retains beneficial ownership of 8,929,071 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; while insider selling can be perceived negatively, the use of a pre-arranged 10b5-1 plan suggests routine portfolio management rather than a reaction to negative company developments.

Positives

• The sale was executed under a pre-established 10b5-1 trading plan, indicating the transaction was planned well in advance rather than based on immediate non-public information.

Negatives

• The sale represents a reduction in the equity position held by a 10% owner, which may be perceived as a lack of long-term confidence or simple portfolio rebalancing.

Risks

• Continued selling by major shareholders could exert downward pressure on the stock price.
• The reliance on 10b5-1 plans does not eliminate the potential for negative market sentiment regarding insider selling.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Management Comments

• The transactions were executed pursuant to a 10b5-1 trading plan adopted by K. Charles Janac, manager of Bayview Legacy, LLC.

Industry Context

StockSavvy.ai notes that insider selling by 10% owners is common for liquidity or diversification purposes and is often pre-planned to avoid regulatory scrutiny, though it remains a signal monitored by institutional investors.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for corporate insiders to sell shares while maintaining compliance with SEC regulations.

Stakeholder Impact

• Shareholders may view the reduction in a major holder's stake as a signal of potential price volatility.

Next Steps

• Continued monitoring of Form 4 filings for further sales by Bayview Legacy, LLC or other insiders.

Key Dates

Keywords

Arteris, AIP, Insider Selling, Form 4, 10b5-1, Bayview Legacy